Caris Life Sciences CAI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 26.98 | 94.75 | 1.61 | 88,411 | 82 | |
| 2025Q3 | 30.25 | 86.28 | 7.97 | 32,642 | 24 | |
| 2025Q2 | 26.72 | 34.21 | -9.23 | -17,988 | -72 | |
| 2025Q1 | 64.54 | -3.57 | -57,952 | -103 | ||
| 2024Q4 | ||||||
| 2024Q2 | -0.35 | -67,011 | -66 | |||
| 2024Q1 | -0.53 | -92,225 | -111 | |||
| 2021Q3 | 83.59 | 2.79 | 66,443 | 51 | ||
| 2021Q2 | 87.75 | 2.05 | 50,839 | 38 | ||
| 2021Q1 | 88.51 | 1.91 | 48,763 | 36 | ||
| 2020Q4 | 94.83 | 0.67 | 46,691 | 14 | ||
| 2020Q3 | 99.55 | 0.75 | 24,868 | 15 | ||
| 2020Q2 | 89.78 | -0.16 | 19,082 | -1 | ||
| 2020Q1 | 92.14 | -0.20 | 16,032 | -1 | ||
| 2019Q4 | 120.78 | 0.59 | 44,402 | 13 | ||
| 2019Q3 | 94.77 | -0.43 | 36,820 | -5 | ||
| 2019Q2 | 128.58 | 0.20 | 26,661 | 9 | ||
| 2019Q1 | 83.38 | 0.87 | 44,121 | 19 | ||
| 2018Q4 | 92.84 | 52,226 | 19 | |||
| 2018Q3 | 94.03 | 1.02 | 39,649 | 22 |